Google Cloud Launches New ‘Accelerators’ to Help Healthcare Companies Improve Health Equity, Patient Flow, and Value-Based Care


Hitesh

Collaboration with organisations like Lifepoint Health, Hackensack Meridian Health, and others will help businesses operate more successfully and provide better patient care. Today at HLTH 2022, Google Cloud unveiled three new Healthcare Data Engine (HDE) accelerators that support organisations in addressing common use cases related to health equity, patient flow, […]

Indivior To Acquire Opiant Pharmaceuticals


Hitesh

According to a definitive agreement between Indivior PLC and Opiant Pharmaceuticals, Inc., which the two companies announced today, Indivior will buy Opiant for an upfront payment of $20.00 per share in cash (roughly $145 million total), plus up to $8.00 per share in contingent value rights (“CVRs”) that could become […]

Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company


Hitesh

Creating a New Paradigm in Precision Medicine for The Company Fulgent Pharma Holdings, Inc., an independent clinical-stage, therapeutics development company focused on the development of cutting-edge cancer treatments, has been acquired by Fulgent Genetics, Inc., a technology-based genetic testing business focused on transforming patient care in oncology, infectious and rare […]

Karyopharm and Menarini Group announce orphan drug designation by the European Commission for selinexor for the treatment of myelofibrosis


Hitesh

The Menarini Group, a prominent privately held international pharmaceutical company, and Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the European Commission (EC) has granted selinexor orphan Medicinal Product Designation. It is intended to be used to treat myelofibrosis (MF). In May 2022, the […]

CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology


Hitesh

CSL Enters Licensing Agreement with Arcturus Therapeutics : Today, CSL Limited reports that its subsidiary, CSL Seqirus, has collaborated and licenced its late-stage self-amplifying mRNA (sa-mRNA) vaccine platform technology to Arcturus Therapeutics Holdings Inc (or “Arcturus Therapeutics”). Future mRNA vaccines are being created by Arcturus Therapeutics. It has created a […]

Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials


Hitesh

Electronic Data Capture in Clinical Trials Boehringer Ingelheim and Medidata, a Dassault Systems firm, today announced a five-year extension of their partnership in the broader field of electronic data collection. The new arrangement includes myMedidata, Medidata’s portfolio of cutting-edge patient-facing technologies aimed at boosting patient centricity and diversity in decentralised […]

Evidation Launches FluSmart, A Direct-to-Person Digital Flu Monitoring Program, To Better Understand Flu in Everyday Life


Hitesh

In order to understand the flu at its earliest stages, people, researchers, and public and private organisations are brought together in FluSmart, a digital flu monitoring programme that was recently introduced by Evidation, the company that connects directly with people to measure health in everyday life. FluSmart, a nationwide programme […]